<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Fish oil: Physiologic effects and administration
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Fish oil: Physiologic effects and administration
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Fish oil: Physiologic effects and administration
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Dariush Mozaffarian, MD, DrPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Mason W Freeman, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sara Swenson, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Dec 05, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ecologic studies in the 1970s reported low rates of coronary heart disease (CHD) death among the Inuit people of Greenland who consumed large amounts of seafood [
         <a href="#rid1">
          1
         </a>
         ]. This observation led to extensive research examining the health effects of seafood consumption and the finding that the long-chain omega-3 polyunsaturated fatty acids in fish oil, eicosapentaenoic acid (20:5n-3), and docosahexaenoic acid (22:6n-3) are important contributors to these benefits  (
         <a class="graphic graphic_figure graphicRef58051" href="/z/d/graphic/58051.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid2">
          2-22
         </a>
         ].
        </p>
        <p>
         This topic will discuss the physiologic effects of fish oil on cardiovascular and metabolic systems as well as issues related to fish oil administration, including preparations, dosing, and safety.
        </p>
        <p>
         The effects of fish oil supplementation on pregnancy and infant outcomes and on dementia are reviewed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/431.html" rel="external">
          "Fish consumption and marine omega-3 fatty acid supplementation in pregnancy"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/83231.html" rel="external">
          "Long-chain polyunsaturated fatty acids (LCPUFA) for preterm and term infants"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5075.html" rel="external">
          "Prevention of dementia", section on 'Omega-3 fatty acids'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2045865195">
         <span class="h1">
          NOMENCLATURE
         </span>
         <span class="headingEndMark">
          —
         </span>
         The two major categories of polyunsaturated fatty acids (PUFAs) are the omega-3 (also called n-3) and omega-6 (n-6) fatty acids, based on the location of the first double bond in the fatty acid chain. The three major dietary omega-3s are eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and alpha-linolenic acid (ALA). EPA and DHA are long-chain omega-3 PUFAs present in fish, shellfish, and (in much lower amounts) some other animal foods. They are the major components of fish oil supplements. ALA is an intermediate-chain omega-3 PUFA present in certain plants and their oils, such as flaxseed and walnuts. When referring to EPA and DHA, common terms include "long-chain omega-3 fatty acids," "seafood-derived omega-3 fatty acids," and "marine omega-3 fatty acids." In this topic, all omega-3 fatty acids are assumed to be long-chain unless otherwise specified [
         <a href="#rid23">
          23
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4079917964">
         <span class="h1">
          OVERVIEW
         </span>
         <span class="headingEndMark">
          —
         </span>
         Given the widespread discussion of the potential benefits of marine omega-3 (n-3) fatty acids in the scientific literature and lay press, patients may have questions about fish oil supplementation, most notably in relation to cardiovascular disease (CVD) reduction. In contrast to many other dietary supplements that have few observed physiologic effects, meta-analyses of clinical trials have shown that marine omega-3 fatty acids (dietary or supplementary) have multiple cardiovascular and metabolic effects  (
         <a class="graphic graphic_figure graphicRef107606" href="/z/d/graphic/107606.html" rel="external">
          figure 2
         </a>
         ) [
         <a href="#rid24">
          24
         </a>
         ]. Although many of these effects (described below) are modest in size and dose-dependent, they provide biologic plausibility for the lower risk of CVD seen in many observational studies and some, but not all, clinical trials of omega-3 fatty acid consumption [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p>
         The US Food and Drug Administration (FDA) considers cardiovascular risk reduction in selected patients with mild hypertriglyceridemia an off-label indication for prescription preparations of omega-3 fatty acids. The FDA has also determined that food labeling stating that consuming marine omega-3 fatty acids in food or dietary supplements may reduce the risk of hypertension and coronary heart disease meets the "credible evidence" standard for a qualified health claim but does not meet the "significant scientific agreement" standard required for an authorized health claim [
         <a href="#rid25">
          25,26
         </a>
         ].
        </p>
        <p>
         These issues are discussed in the following topics:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7573.html" rel="external">
          "Overview of primary prevention of cardiovascular disease", section on 'Omega-3 fatty acids'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1505.html" rel="external">
          "Prevention of cardiovascular disease events in those with established disease (secondary prevention) or at very high risk", section on 'Marine omega-3 fatty acids'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4570.html" rel="external">
          "Hypertriglyceridemia in adults: Management", section on 'Treatment goals'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4561.html" rel="external">
          "Lipid management with diet or dietary supplements"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2029219246">
         <span class="h1">
          POTENTIAL EFFECTS ON CARDIOVASCULAR AND METABOLIC SYSTEMS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Effects on specific cardiovascular and metabolic systems are described below and vary by dose and time  (
         <a class="graphic graphic_figure graphicRef78417" href="/z/d/graphic/78417.html" rel="external">
          figure 3
         </a>
         ) [
         <a href="#rid21">
          21
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4005991862">
         <span class="h2">
          System effects
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cardiovascular outcomes
         </strong>
         – The role of fish oil in preventing cardiovascular outcomes (eg, stroke, myocardial infarction) is unclear. Several large clinical trials in patients with hypertriglyceridemia have yielded mixed results on whether omega-3 fatty acid consumption reduces the risk of cardiovascular events or death. This is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4570.html" rel="external">
          "Hypertriglyceridemia in adults: Management", section on 'Effects on cardiovascular outcomes'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Lipids
         </strong>
         – Consumption of high-dose omega-3 fatty acids lowers serum triglyceride concentrations by 25 to 50 percent, an effect within the range of efficacy of other triglyceride-lowering drugs [
         <a href="#rid27">
          27-29
         </a>
         ]. The dose-response appears linear, with little triglyceride lowering with dietary doses or low-dose eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA; &lt;1 g/day) and more significant lowering with higher doses (3 to 4 g/day)  (
         <a class="graphic graphic_figure graphicRef78417" href="/z/d/graphic/78417.html" rel="external">
          figure 3
         </a>
         ) [
         <a href="#rid30">
          30
         </a>
         ]. The clinical use of fish oil on lipid lowering, including among patients with hypertriglyceridemia, is discussed in more detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/4570.html" rel="external">
          "Hypertriglyceridemia in adults: Management", section on 'Treatment goals'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4561.html" rel="external">
          "Lipid management with diet or dietary supplements", section on 'Omega-3 fatty acids'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Both EPA and DHA reduce fasting and postprandial triglycerides, mainly by reducing hepatic very low-density lipoprotein (VLDL) cholesterol production but also by increased conversion of VLDL to intermediate-density lipoprotein and low-density lipoprotein (LDL) [
         <a href="#rid31">
          31,32
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Atrial fibrillation
         </strong>
         – Although observational studies suggest that dietary EPA+DHA is associated with lower incidence of atrial fibrillation, neither low- nor high-dose fish oil supplementation prevents recurrent or postsurgical atrial fibrillation in interventional studies [
         <a href="#rid33">
          33-38
         </a>
         ]. In contrast, high-dose EPA and/or DHA supplementation is associated with a modest increase in incidence of atrial fibrillation in meta-analyses of trials [
         <a href="#rid39">
          39-42
         </a>
         ]. This is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4570.html" rel="external">
          "Hypertriglyceridemia in adults: Management", section on 'Safety'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Blood pressure and systemic vascular resistance
         </strong>
         – Fish oil consumption can lower systolic and diastolic blood pressure (BP), including reductions in individuals with untreated hypertension.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In a meta-analysis of 70 randomized trials conducted among adults (excluding persons with treated hypertension, preexisting cardiovascular disease (CVD), other significant disease process, or secondary hypertension), EPA and DHA supplementation reduced systolic BP by 1.52 mmHg and diastolic BP by 0.99 mmHg [
         <a href="#rid43">
          43
         </a>
         ]. BP was reduced in both normotensive and hypertensive patients. The largest effects were seen in those with untreated hypertension, with systolic and diastolic BP reductions of 4.51 and 3.05 mmHg, respectively.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In a meta-analysis of 12 randomized controlled trials among 1028 children or adolescents with overweight or obesity, fish oil supplementation lowered systolic blood pressure by 2.46 mmHg, with no significant effect on diastolic blood pressure [
         <a href="#rid44">
          44
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Animal studies and observational studies in humans found that the BP-lowering effect of fish oil results from a reduction in systemic vascular resistance (ie, lower arteriolar resistance), with unchanged cardiac output [
         <a href="#rid45">
          45,46
         </a>
         ]. In vitro studies demonstrate that omega-3 polyunsaturated fatty acids (n-3 PUFA) induce nitric oxide production, modulate endothelial activation, and modify the location and function of cell membrane caveolae proteins, including endothelial nitric oxide synthase (eNOS) [
         <a href="#rid47">
          47-50
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In short-term trials in humans, EPA and DHA consumption increases biomarkers of nitric oxide production, mitigates peripheral vasoconstrictive responses to
         <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">
          norepinephrine
         </a>
         and angiotensin II, improves arterial wall compliance, and enhances vasodilatory responses [
         <a href="#rid51">
          51-55
         </a>
         ]. In a meta-analysis of 14 randomized controlled trials, fish oil supplementation reduced pulse wave velocity, a measure of arterial stiffness [
         <a href="#rid56">
          56
         </a>
         ]. These effects, separately or in sum, could account for lowering of systemic vascular resistance.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Heart rate and heart rate variability
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Fish oil appears to reduce heart rate (HR). In a meta-analysis of 30 randomized trials, fish oil supplementation (median dose 3.5 g/day, median duration eight weeks) reduced resting HR by 1.6 beats per minute (bpm) [
         <a href="#rid57">
          57
         </a>
         ] and by 2.2 bpm in an updated meta-analysis of 51 trials [
         <a href="#rid58">
          58
         </a>
         ]. In these trials, the HR-lowering effect did not appear to be dose-dependent at the doses used (range 1 to 15 g/day). By contrast, at lower (dietary) doses in observational studies, dose appears important at least to a threshold of approximately 300 mg/day EPA+DHA  (
         <a class="graphic graphic_figure graphicRef78417" href="/z/d/graphic/78417.html" rel="external">
          figure 3
         </a>
         ) [
         <a href="#rid45">
          45,57,59
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Experimental studies in animals suggest that HR lowering could result from direct cardiac electrophysiologic effects of fish oil [
         <a href="#rid18">
          18,19,60
         </a>
         ]. EPA and DHA may also lower HR in humans by more indirect effects, such as by improving left ventricular diastolic filling or augmenting vagal tone [
         <a href="#rid61">
          61
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The effect of fish oil on heart rate variability (HRV) is uncertain. HRV is influenced by underlying resting HR, autonomic function, circadian rhythms, and underlying cardiac health. Results from trials evaluating fish oil supplementation and HRV have been inconsistent possibly due to small numbers, variable doses of fish oil used, relatively short durations of intake (weeks to months), or limited periods of HRV assessment [
         <a href="#rid62">
          62-65
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Although animal and in vitro studies demonstrate an effect of omega3 fatty acids on myocyte electrophysiology, confirmation of a direct antiarrhythmic effect on human hearts is limited by the absence of any reliable and easily obtainable biomarker of such effects [
         <a href="#rid17">
          17-19,66-68
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cardiac function
         </strong>
         – Some evidence suggests that fish oil may have effects on various aspects of cardiac function.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Left ventricular diastolic filling consists of two phases: an early phase of active (energy-dependent) relaxation and a second phase of more passive (compliance-dependent) filling (with a final brief phase due to atrial contraction). Abnormalities of early relaxation are among the earliest signs of ischemic heart disease, while abnormal passive filling (reduced compliance) often results from longstanding hypertensive heart disease or ischemic heart disease. In a small trial of healthy men, seven weeks of fish oil (4 g/day) improved the early phase of diastolic filling [
         <a href="#rid69">
          69
         </a>
         ]. This relatively acute improvement suggests a functional or metabolic, rather than structural, effect on energy-dependent filling. In a small trial among patients with ischemic heart failure, eight weeks of fish oil (2 g/day) versus placebo reduced the E/e' ratio, a measure of abnormal diastolic filling, by -9.47 versus -2.1 percent [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Fish oil may also improve the second (compliance-dependent) phase of diastolic filling by augmenting or preventing decline in ventricular compliance. In a cohort study of older adults, habitual modest fish consumption was associated with a trend toward lower electrocardiographically defined left ventricular mass, a measure of left ventricular size and hypertrophy, and with a higher E/A ratio, a measure of more normal diastolic filling [
         <a href="#rid45">
          45
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In healthy adults, fish oil from either diet or supplementation does not appear to impact cardiac systolic function [
         <a href="#rid45">
          45,69,71
         </a>
         ], except for higher-cardiac stroke volume as a result of slower resting heart rate (increasing filling time) and enhanced diastolic filling [
         <a href="#rid45">
          45,72
         </a>
         ]. However, in patients with established heart failure, fish oil consumption improves left ventricular ejection fraction [
         <a href="#rid73">
          73,74
         </a>
         ]. In one randomized trial of 16 athletes, fish oil consumption improved myocardial efficiency, reducing myocardial oxygen demand without a decrement in performance [
         <a href="#rid75">
          75
         </a>
         ]. In another trial among 31 patients with ischemic heart failure, eight weeks of fish oil supplementation improved left ventricle ejection fraction by 4.7 versus 1.7 percent in the placebo group [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Each of these preliminary findings on fish oil and cardiac systolic and diastolic function require confirmation in larger studies.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Endothelial function
         </strong>
         – Several, though not all, randomized trials in humans have reported that fish oil consumption lowers circulating markers of endothelial dysfunction, such as E-selectin, vascular cell adhesion molecule 1 (VCAM-1), and intercellular adhesion molecule 1 (ICAM-1) [
         <a href="#rid76">
          76,77
         </a>
         ]. In a meta-analysis of 16 randomized, placebo-controlled trials including 901 participants, compared with placebo, fish oil increased flow-mediated vasodilation, a noninvasive surrogate for endothelial function (higher flow-mediated vasodilation reflects improved endothelial function) [
         <a href="#rid78">
          78
         </a>
         ]. These trials used a variety of doses (range: 0.45 to 4.5 g/day) over a median treatment duration of 56 days.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Bleeding/platelet function
         </strong>
         – Clinically apparent effects of fish oil on bleeding are not evident at commonly used doses of up to 4 g/day. High doses of EPA (3 to 15 g/day) increase bleeding time, but this has not been associated with higher rates of clinical bleeding [
         <a href="#rid79">
          79
         </a>
         ]. Omega-3 fatty acids suppress platelet activating factor in experimental in vitro studies, but in human trials significant effects of fish oil consumption on platelet aggregation are not reliably seen [
         <a href="#rid29">
          29
         </a>
         ]. Clinical effects on bleeding have not been seen. (See
         <a class="local">
          'Bleeding'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Inflammation
         </strong>
         – Fish oil may have several anti-inflammatory effects due to the role of EPA and DHA as precursors to specific eicosanoids and other inflammatory mediators as well as resolvins, protectins, and maresins that play crucial roles in active resolution of inflammation [
         <a href="#rid80">
          80,81
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In meta-analyses of randomized trials, fish oil supplementation had a lowering effect on C-reactive protein (CRP), interleukin 6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha) [
         <a href="#rid82">
          82-84
         </a>
         ]. Significant reductions in CRP have also been seen in meta-analyses of randomized trials of fish oil supplementation among patients with end-stage kidney disease [
         <a href="#rid85">
          85
         </a>
         ], HIV infection [
         <a href="#rid86">
          86
         </a>
         ], and polycystic ovary syndrome [
         <a href="#rid87">
          87
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Among adults with elevated high-sensitivity CRP (hs-CRP, ≥2 mcg/mL) and metabolic risk factors, both EPA and DHA (supplemented separately, 3 g/day for 10 weeks each) reduced levels of inflammatory markers, with both shared and differential effects related to distinct downstream lipid mediators including specialized pro-resolving lipid mediators (SPMs) [
         <a href="#rid88">
          88
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In a network meta-analysis, EPA and DHA evaluated separately had similar effects on reducing CRP, IL-6, and TNF-alpha [
         <a href="#rid89">
          89
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A discussion of fish oil for use in arthritis is provided separately. (See
         <a class="medical medical_review" href="/z/d/html/7979.html" rel="external">
          "Complementary and alternative therapies for rheumatic disorders", section on 'Fish and botanic oils'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Glucose and insulin
         </strong>
         – Although fish oil improves markers of the metabolic syndrome, these biomarker improvements have not been proven to produce significant clinical benefits in patients with type 2 diabetes mellitus [
         <a href="#rid90">
          90
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In a meta-analysis of trials examining the effects of fish oil on insulin sensitivity in adults, omega-3 fatty acids did not appear to have major effects on insulin sensitivity in the general population or the subgroup with type 2 diabetes [
         <a href="#rid91">
          91,92
         </a>
         ]. By contrast, in a meta-analysis of 13 trials with 1132 children, omega-3 fatty acids significantly improved insulin sensitivity [
         <a href="#rid93">
          93
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In a meta-analysis of trials on the effect of fish oil on plasma adiponectin, omega-3 fatty acid supplementation modestly increased adiponectin levels compared with placebo [
         <a href="#rid94">
          94
         </a>
         ]. Increased adiponectin was also observed in meta-analyses of randomized trials of fish oil supplementation among patients with diabetes [
         <a href="#rid95">
          95
         </a>
         ] and polycystic ovary syndrome [
         <a href="#rid87">
          87
         </a>
         ]. In a network meta-analysis, EPA and DHA evaluated separately produced similar increases in plasma adiponectin [
         <a href="#rid89">
          89
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Adiposity and body composition
         </strong>
         – Fish oil may alter body weight and body composition.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In a meta-analysis of 11 randomized controlled trials including 617 persons with overweight or obesity, supplementation reduced waist circumference by 0.53 cm but did not significantly affect body mass index (BMI) [
         <a href="#rid96">
          96
         </a>
         ]. By contrast, in a meta-analysis of 12 randomized controlled trials including 1028 children and adolescents with overweight or obesity, fish oil supplementation reduced BMI by 0.96 kg/m
         <sup>
          2
         </sup>
         but did not significantly reduce waist circumference [
         <a href="#rid44">
          44
         </a>
         ]. In 22 randomized controlled trials with 1366 patients with metabolic dysfunction-associated steatotic liver disease (previously nonalcoholic fatty liver disease), fish oil supplementation reduced liver fat compared with placebo (pooled risk ratio 1.52, 95% CI 1.09-2.13) and also reduced BMI by 0.46 kg/m
         <sup>
          2
         </sup>
         [
         <a href="#rid97">
          97
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The clinical role of omega-3 fatty acid supplementation in individuals with hepatic steatosis is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/3600.html" rel="external">
          "Management of nonalcoholic fatty liver disease in adults", section on 'Therapies with uncertain benefit'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3537825944">
         <span class="h2">
          Pharmacokinetics and pharmacodynamics
         </span>
         <span class="headingEndMark">
          —
         </span>
         EPA and DHA are absorbed from the gastrointestinal tract and, as with other dietary fatty acids, are transported to the liver largely as triglycerides in chylomicron particles. From the liver, EPA and DHA are released into the circulation as triglycerides in lipoprotein particles (such as LDL cholesterol and high-density lipoprotein [HDL] cholesterol) and as plasma phospholipids. Smaller amounts circulate as free fatty acids, largely bound to albumin.
        </p>
        <p>
         EPA and DHA are incorporated into cell membrane phospholipids throughout the body, with particular enrichment in the heart and brain, and stored in adipose tissue as triglycerides. Consumption of fish oil increases the concentration of EPA and DHA in plasma lipids and membrane phospholipids within days, with maximal incorporation at approximately two weeks [
         <a href="#rid98">
          98
         </a>
         ]. Increases are dose-dependent but nonlinear, with a larger increase at lower doses and then smaller increments with increasing doses [
         <a href="#rid98">
          98
         </a>
         ].
        </p>
        <p>
         Physiologic effects of omega-3 fatty acids appear to result from altered cell membrane fluidity and function following incorporation of these fatty acids into cell membranes, which then modulate protein receptor responses; binding of omega-3 fatty acids to cytoplasmic lipid-binding proteins (eg, peroxisome proliferator-activated receptor [PPAR]-gamma) that regulate gene transcription; direct interaction and influence of omega-3 fatty acids on membrane channels and proteins, such as G-protein-coupled receptors; and production of omega-3 fatty acid metabolites such as eicosanoids and specialized pro-resolving mediators (SPMs) including resolvins or protectins  (
         <a class="graphic graphic_figure graphicRef107607" href="/z/d/graphic/107607.html" rel="external">
          figure 4
         </a>
         ).
        </p>
        <p>
         Following cessation of consumption, washout occurs within one to three days in plasma lipid fractions but takes much longer (one to two months) for cell membranes [
         <a href="#rid98">
          98
         </a>
         ]. Relatively minor pharmacokinetic differences are seen between different oral formulations of fish oil (eg, triglycerides versus ethyl esters) [
         <a href="#rid99">
          99
         </a>
         ].
        </p>
        <p>
         Compared with EPA and DHA, other omega-3 fatty acids such as docosapentaenoic acid (DPA, 22:5n-3) are present in much smaller amounts in fish oil but may be biologically active and have important metabolites following consumption [
         <a href="#rid100">
          100
         </a>
         ]. DPA concentrations in blood and tissues appear to reflect endogenous synthesis (from dietary EPA) to a greater extent than direct dietary DPA consumption. EPA can also be metabolized to prostaglandin E3, an eicosanoid that mediates inflammation and thrombosis. Very little EPA (&lt;5 percent) is converted to DHA, although this conversion occurs to a greater extent in women, particularly during pregnancy [
         <a href="#rid101">
          101
         </a>
         ].
        </p>
        <p>
         For most health effects, the relative biologic importance of EPA versus DHA versus their associated metabolites is not well-established, except for early brain development for which DHA appears to be more important [
         <a href="#rid102">
          102-105
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2698107210">
         <span class="h2">
          Role of dose and duration
         </span>
         <span class="headingEndMark">
          —
         </span>
         Generally speaking, the physiologic effects of fish oil occur within weeks to months of habitual consumption. At typical dietary intakes (&lt;300 to 500 mg/day), compared with little or no intake, observational studies suggest lower risk of fatal coronary heart disease and sudden death, suggesting that antiarrhythmic effects, if present, may predominate. With low-dose supplements (approximately 1 g/day), the additional physiologic effects described above may have small to modest impact on other clinical outcomes. With high-dose supplements (&gt;2 to 3 g/day), additional physiologic effects such as triglyceride lowering become more meaningful and may lead to modest reductions in total cardiovascular events over months to years [
         <a href="#rid20">
          20,21,40,106-110
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H25">
         <span class="h1">
          ADMINISTRATION
         </span>
        </p>
        <p class="headingAnchor" id="H26">
         <span class="h2">
          Preparations
         </span>
         <span class="headingEndMark">
          —
         </span>
         <a class="drug drug_general" data-topicid="10255" href="/z/d/drug information/10255.html" rel="external">
          Omega-3-acid ethyl esters
         </a>
         are available by prescription, or as nutritional supplements (not regulated by the US Food and Drug Administration [FDA]). These doses of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) contained in these supplements are significantly lower than those used to treat hypertriglyceridemia or in studies of fish oil to reduce cardiovascular endpoints [
         <a href="#rid111">
          111
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4570.html" rel="external">
          "Hypertriglyceridemia in adults: Management", section on 'Marine omega-3 fatty acids'
         </a>
         .)
        </p>
        <p>
         These preparations are generally omega-3 polyunsaturated fatty acids (n-3 PUFA) as ethyl esters derived from small pelagic fish used for fish feed. Omega-3 fatty acid supplements can also be derived from formulations produced by algae. Krill oil, made from the small crustacean that is its namesake, also contains n-3 PUFA, but as phospholipids and free fatty acids rather than ethyl esters.
        </p>
        <p>
         Preparations available by prescription include the following [
         <a href="#rid112">
          112
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="10255" href="/z/d/drug information/10255.html" rel="external">
          Omega-3-acid ethyl esters
         </a>
         (Lovaza) – Each 1 g capsule contains omega-3 fatty acids as ethyl esters sourced from fish oils, including approximately 465 mg of EPA and 375 mg of DHA.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="86044" href="/z/d/drug information/86044.html" rel="external">
          Icosapent ethyl
         </a>
         (Vascepa) – Each 1 g capsule contains approximately 878 mg of highly purified EPA as an ethyl ester (also available in a 0.5 g capsule).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Omega-3 phospholipid (CaPre, investigational) – Each 1 g capsule contains omega-3 fatty acids as phospholipids (approximately 60 percent) and free fatty acids (approximately 40 percent) sourced from krill oils, including approximately 310 mg of EPA and DHA.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Omega-3-carboxylic acids (Epanova) – Each 1 g capsule contains omega-3 fatty acids as free fatty acids, including approximately 550 mg of EPA and 200 mg of DHA. After the phase III Long-Term Outcomes Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia (STRENGTH) trial failed to demonstrate Epanova's superiority over placebo in reducing cardiovascular endpoints, its production was discontinued in the United States [
         <a href="#rid113">
          113
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4570.html" rel="external">
          "Hypertriglyceridemia in adults: Management", section on 'Effects on cardiovascular outcomes'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         The choice of specific preparations for treating hypertriglyceridemia is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4570.html" rel="external">
          "Hypertriglyceridemia in adults: Management", section on 'Choice of agent'
         </a>
         .)
        </p>
        <p>
         Supplement products commonly available at major drug or health food stores contain the labeled amount of EPA and DHA [
         <a href="#rid114">
          114
         </a>
         ]. Different specific fish oil supplements contain varying amounts of EPA and DHA, depending on their formulation. Most formulations contain between 20 and 40 percent total EPA+DHA combined with other omega-3 fatty acids, monounsaturated fats, saturated fats, and gelatin or
         <a class="drug drug_general" data-topicid="8959" href="/z/d/drug information/8959.html" rel="external">
          glycerin
         </a>
         [
         <a href="#rid115">
          115,116
         </a>
         ]. Consequently, a 1 g supplement capsule typically contains between 200 and 400 mg of EPA and/or DHA.
        </p>
        <p>
         For more information on preparations, refer to the Lexicomp drug information monograph for
         <a class="drug drug_general" data-topicid="10255" href="/z/d/drug information/10255.html" rel="external">
          omega-3-acid ethyl esters
         </a>
         (fish oil) included within UpToDate.
        </p>
        <p class="headingAnchor" id="H53590247">
         <span class="h2">
          Absorption
         </span>
         <span class="headingEndMark">
          —
         </span>
         Fish oil supplements should be taken with a meal that contains fats, as the gastrointestinal absorption of ethyl ester and triglyceride formulations of omega-3 fatty acids is highest when consumed with a high-fat meal. The absorption of formulations that are predominantly free fatty acids (eg, Epanova) or phospholipids (eg, CaPre) have less dependence on being consumed with a meal or a high-fat meal. While absorption rates of these various formulations can vary, all omega-3 fatty acid formulations raise blood and tissue levels compared with not taking such supplements.
        </p>
        <p class="headingAnchor" id="H2959512540">
         <span class="h2">
          Side effects
         </span>
         <span class="headingEndMark">
          —
         </span>
         In a pooled analysis of randomized clinical trials, the most common side effects of fish oil consumption were gastrointestinal disturbances such as nausea, occurring in approximately 4 percent of individuals at doses below 3 g/day and in approximately 20 percent of individuals at doses of 4 g/day or higher [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p>
         Perhaps the most common symptom causing discontinuation of fish oil supplements is "fishy taste" following eructation (burping). Freezing the fish oil, switching to a different formulation, consuming with meals, or changing intake to a different time of day may minimize this symptom in some people.
        </p>
        <p class="headingAnchor" id="H28">
         <span class="h1">
          SAFETY
         </span>
         <span class="headingEndMark">
          —
         </span>
         In small trials, fish oil capsules up to 12 g/day (containing 6 g/day omega-3 fatty acids ) have been administered for more than two years without serious adverse events [
         <a href="#rid117">
          117,118
         </a>
         ].
        </p>
        <p>
         Although even these very high doses of fish oil appear to be safe, the US Food and Drug Administration (FDA) recommends that the general population not exceed 3 g/day of eicosapentaenoic acid and docosahexaenoic acid combined, with up to 2 g/day from dietary supplements, without the guidance of a clinician [
         <a href="#rid119">
          119,120
         </a>
         ]. Higher dosing is approved by the FDA under the guidance of a clinician.
        </p>
        <p>
         The FDA has approved fish oil at a dose of 4 g/day for prescription therapy of hypertriglyceridemia [
         <a href="#rid115">
          115
         </a>
         ]. In the REDUCE-IT trial, which used this formulation, overall rates of adverse events and serious adverse events were generally similar between treatment and placebo groups, with a few small differences [
         <a href="#rid121">
          121
         </a>
         ]. The few differences should be interpreted cautiously given multiple comparisons and lack of prespecified hypothesis or plausible biology for such effects.
        </p>
        <p class="headingAnchor" id="H29">
         <span class="h2">
          Bleeding
         </span>
         <span class="headingEndMark">
          —
         </span>
         In a 2020 systematic review of omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease, increased intake of long-chain omega-3 fatty acids did not increase the risk of bleeding [
         <a href="#rid122">
          122
         </a>
         ].
        </p>
        <p>
         In a detailed secondary analysis of the OPERA trial, high-dose omega-3 fatty acids (8 to 10 g loading dose over two to five days preoperatively, followed by 2 g/day postoperatively) did not increase bleeding risk among a multinational general population of 1516 patients undergoing cardiac surgery [
         <a href="#rid123">
          123
         </a>
         ]. Compared with placebo, risk of BRAC (Bleeding Academic Research Consortium) bleeding was not higher in the fish oil group (odds ratio [OR] 0.81; 95% CI, 0.53-1.24; absolute risk difference, 1.1 percent lower [95% CI, -3.0 to 1.8]) and was associated with significantly fewer total units of red blood cell transfusions (1.61 versus 1.92 units in fish oil versus placebo). These findings suggest little need to hold fish oil or delay procedures before cardiac surgery.
        </p>
        <p class="headingAnchor" id="H30">
         <span class="h2">
          Contaminants
         </span>
         <span class="headingEndMark">
          —
         </span>
         Commercially available fish oil capsules contain no appreciable mercury, which is tightly bound to fish proteins rather than present in the lipid fraction [
         <a href="#rid21">
          21,124
         </a>
         ].
        </p>
        <p>
         Significant exposure to contaminants from fish oil is not a clinical concern [
         <a href="#rid21">
          21
         </a>
         ]. Fish oil capsules contain small amounts of polychlorinated biphenyls (PCBs; 0 to 450 ng/g) [
         <a href="#rid125">
          125,126
         </a>
         ] and dioxins (0.2 to 11 TEQ pg/g) [
         <a href="#rid127">
          127,128
         </a>
         ], with concentrations proportional to those in the fish species from which the fish oil is derived. Notably, given the small absolute quantities of fish oil that would be consumed (1 to 4 g/day), the absolute amounts of PCBs or dioxins that can be consumed from fish oil supplementation is extremely low.
        </p>
        <p>
         Maternal ingestion of fish during pregnancy and lactation are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/431.html" rel="external">
          "Fish consumption and marine omega-3 fatty acid supplementation in pregnancy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4960.html" rel="external">
          "Maternal nutrition during lactation", section on 'Fish intake'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2251422914">
         <span class="h2">
          Cancer risk
         </span>
         <span class="headingEndMark">
          —
         </span>
         Overall, the available evidence does not support any major effects of fish or fish oil consumption on cancer risk. Systematic reviews and meta-analyses of numerous large prospective observational studies have generally found no significant effects of fish consumption on risk of any type of cancer [
         <a href="#rid129">
          129,130
         </a>
         ], nor have randomized trials of fish oil [
         <a href="#rid9">
          9,22,121
         </a>
         ]. Some studies [
         <a href="#rid131">
          131-133
         </a>
         ], though not all [
         <a href="#rid134">
          134
         </a>
         ], have suggested an association between higher levels of omega-3 fatty acids and increased risk of prostate cancer; however, meta-analyses of all studies found no consistent associations between dietary or blood biomarker levels of omega-3 fatty acids and prostate cancer [
         <a href="#rid135">
          135,136
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2491660350">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/111039.html" rel="external">
          "Society guideline links: Healthy diet in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1072002081">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Active constituents of fish oil
         </strong>
         – Animal and human studies have identified the long-chain omega-3 polyunsaturated fatty acids (n-3 PUFA), eicosapentaenoic acid (EPA, 20:5n-3), and docosahexaenoic acid (DHA, 22:6n-3) as major active constituents in fish/seafood and fish oil. (See
         <a class="local">
          'Potential effects on cardiovascular and metabolic systems'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Potential clinical role
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Patients with hypertriglyceridemia
         </strong>
         – High daily doses of EPA and/or DHA (3 to 4 g/day) can lower serum triglyceride levels by 25 to 50 percent. The role of fish oil in the treatment of hypertriglyceridemia is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4570.html" rel="external">
          "Hypertriglyceridemia in adults: Management", section on 'Marine omega-3 fatty acids'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Other patients
         </strong>
         – The role of omega-3 fatty acid supplementation in lipid management in patients without hypertriglyceridemia is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/7573.html" rel="external">
          "Overview of primary prevention of cardiovascular disease", section on 'Omega-3 fatty acids'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4561.html" rel="external">
          "Lipid management with diet or dietary supplements"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Atrial fibrillation
         </strong>
         – Omega-3 fatty acids do not appear to reduce the risk of recurrent atrial fibrillation, and high-dose fish oil supplementation may increase the risk of atrial fibrillation. (See
         <a class="local">
          'System effects'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/4570.html" rel="external">
          "Hypertriglyceridemia in adults: Management", section on 'Safety'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other cardiovascular effects
         </strong>
         – Based on the mixed findings of trials, the efficacy of fish oil supplementation for reducing clinical cardiovascular outcomes, such as cardiovascular mortality, myocardial infarction, and stroke, remains unclear. While some studies suggest that omega-3 fatty acids (dietary or supplementary) have potential cardiovascular and metabolic benefits  (
         <a class="graphic graphic_figure graphicRef107606" href="/z/d/graphic/107606.html" rel="external">
          figure 2
         </a>
         ), these effects are modest in size and dose dependent. (See
         <a class="local">
          'Overview'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/4570.html" rel="external">
          "Hypertriglyceridemia in adults: Management", section on 'Effects on cardiovascular outcomes'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preparations
         </strong>
         – Fish oil preparations are available by prescription or as nutritional supplements, each of which have a different composition and dose. They are generally derived from small pelagic fish used for fish feed or from formulations produced by algae. (See
         <a class="local">
          'Preparations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Safety
         </strong>
         – Existing evidence suggests that fish oil supplements are safe. They have not been associated with an increased risk of bleeding or cancer, and significant exposure to contaminants from fish oil is not a major concern. The US Food and Drug Administration advises the general population not to exceed 3 g/day of EPA and DHA combined, with up to 2 g/day from dietary supplements, without the guidance of a clinician. (See
         <a class="local">
          'Overview'
         </a>
         above and
         <a class="local">
          'Safety'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li class="breakAll">
          Bang HO, Dyerberg J. Lipid metabolism and ischemic heart disease in Greenland Eskimos. In: Advances in nutrition research, Draper H (Ed), Plenum Press, New York 1980. p.1–22.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985; 312:1205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989; 2:757.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dolecek TA, Granditis G. Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT). World Rev Nutr Diet 1991; 66:205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Siscovick DS, Raghunathan TE, King I, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995; 274:1363.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kromhout D, Feskens EJ, Bowles CH. The protective effect of a small amount of fish on coronary heart disease mortality in an elderly population. Int J Epidemiol 1995; 24:340.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Daviglus ML, Stamler J, Orencia AJ, et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 1997; 336:1046.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Albert CM, Hennekens CH, O'Donnell CJ, et al. Fish consumption and risk of sudden cardiac death. JAMA 1998; 279:23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999; 354:447.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oomen CM, Feskens EJ, Räsänen L, et al. Fish consumption and coronary heart disease mortality in Finland, Italy, and The Netherlands. Am J Epidemiol 2000; 151:999.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yuan JM, Ross RK, Gao YT, Yu MC. Fish and shellfish consumption in relation to death from myocardial infarction among men in Shanghai, China. Am J Epidemiol 2001; 154:809.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hu FB, Bronner L, Willett WC, et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 2002; 287:1815.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Albert CM, Campos H, Stampfer MJ, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002; 346:1113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lemaitre RN, King IB, Mozaffarian D, et al. n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study. Am J Clin Nutr 2003; 77:319.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mozaffarian D, Lemaitre RN, Kuller LH, et al. Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation 2003; 107:1372.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mozaffarian D, Ascherio A, Hu FB, et al. Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation 2005; 111:157.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kang JX, Leaf A. Prevention of fatal cardiac arrhythmias by polyunsaturated fatty acids. Am J Clin Nutr 2000; 71:202S.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McLennan PL. Myocardial membrane fatty acids and the antiarrhythmic actions of dietary fish oil in animal models. Lipids 2001; 36 Suppl:S111.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leaf A, Kang JX, Xiao YF, Billman GE. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 2003; 107:2646.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang C, Harris WS, Chung M, et al. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 2006; 84:5.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006; 296:1885.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007; 369:1090.
          </a>
         </li>
         <li class="breakAll">
          Omega-3 fatty acids: Fact sheet for health professionals. National Institutes of Health Office of Dietary Supplements. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 2011; 58:2047.
          </a>
         </li>
         <li class="breakAll">
          FDA announces new qualified health claims for EPA and DHA omega-3 consumption and the risk of hypertension and coronary heart disease. US Food and Drug Administration, 2019. https://www.fda.gov/food/cfsan-constituent-updates/fda-announces-new-qualified-health-claims-epa-and-dha-omega-3-consumption-and-risk-hypertension-and.
         </li>
         <li class="breakAll">
          Questions and answers on health claims in food labeling. US Food and Drug Administration. https://www.fda.gov/food/food-labeling-nutrition/questions-and-answers-health-claims-food-labeling (Accessed on December 02, 2019).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harris WS. n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997; 65:1645S.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Balk EM, Lichtenstein AH, Chung M, et al. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 2006; 189:19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang C, Chung M, Lichtenstein A, et al. Effects of omega-3 fatty acids on cardiovascular disease. Evid Rep Technol Assess (Summ) 2004; :1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brinton EA, Ballantyne CM, Guyton JR, et al. Lipid Effects of Icosapent Ethyl in Women with Diabetes Mellitus and Persistent High Triglycerides on Statin Treatment: ANCHOR Trial Subanalysis. J Womens Health (Larchmt) 2018; 27:1170.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harris WS, Bulchandani D. Why do omega-3 fatty acids lower serum triglycerides? Curr Opin Lipidol 2006; 17:387.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oscarsson J, Hurt-Camejo E. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review. Lipids Health Dis 2017; 16:149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mariani J, Doval HC, Nul D, et al. N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc 2013; 2:e005033.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nigam A, Talajic M, Roy D, et al. Fish oil for the reduction of atrial fibrillation recurrence, inflammation, and oxidative stress. J Am Coll Cardiol 2014; 64:1441.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kowey PR, Reiffel JA, Ellenbogen KA, et al. Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial. JAMA 2010; 304:2363.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Macchia A, Grancelli H, Varini S, et al. Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial. J Am Coll Cardiol 2013; 61:463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Darghosian L, Free M, Li J, et al. Effect of omega-three polyunsaturated fatty acids on inflammation, oxidative stress, and recurrence of atrial fibrillation. Am J Cardiol 2015; 115:196.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mozaffarian D, Wu JH, de Oliveira Otto MC, et al. Fish oil and post-operative atrial fibrillation: a meta-analysis of randomized controlled trials. J Am Coll Cardiol 2013; 61:2194.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gencer B, Djousse L, Al-Ramady OT, et al. Effect of Long-Term Marine ɷ-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis. Circulation 2021; 144:1981.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bhatt DL, Steg PG, Miller M, et al. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med 2019; 380:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kalstad AA, Myhre PL, Laake K, et al. Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction: A Randomized, Controlled Trial. Circulation 2021; 143:528.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nicholls SJ, Lincoff AM, Garcia M, et al. Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial. JAMA 2020; 324:2268.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller PE, Van Elswyk M, Alexander DD. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials. Am J Hypertens 2014; 27:885.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu S, Zhu C, Wang Z, et al. Effects of Fish Oil Supplementation on Cardiometabolic Risk Factors in Overweight or Obese Children and Adolescents: A Meta-Analysis of Randomized Controlled Trials. Front Pediatr 2021; 9:604469.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mozaffarian D, Gottdiener JS, Siscovick DS. Intake of tuna or other broiled or baked fish versus fried fish and cardiac structure, function, and hemodynamics. Am J Cardiol 2006; 97:216.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Demaison L, Blet J, Sergiel JP, et al. Effect of dietary polyunsaturated fatty acids on contractile function of hearts isolated from sedentary and trained rats. Reprod Nutr Dev 2000; 40:113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Omura M, Kobayashi S, Mizukami Y, et al. Eicosapentaenoic acid (EPA) induces Ca(2+)-independent activation and translocation of endothelial nitric oxide synthase and endothelium-dependent vasorelaxation. FEBS Lett 2001; 487:361.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Caterina R, Liao JK, Libby P. Fatty acid modulation of endothelial activation. Am J Clin Nutr 2000; 71:213S.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li Q, Zhang Q, Wang M, et al. Eicosapentaenoic acid modifies lipid composition in caveolae and induces translocation of endothelial nitric oxide synthase. Biochimie 2007; 89:169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li Q, Zhang Q, Wang M, et al. Docosahexaenoic acid affects endothelial nitric oxide synthase in caveolae. Arch Biochem Biophys 2007; 466:250.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kenny D, Warltier DC, Pleuss JA, et al. Effect of omega-3 fatty acids on the vascular response to angiotensin in normotensive men. Am J Cardiol 1992; 70:1347.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chin JP, Gust AP, Nestel PJ, Dart AM. Marine oils dose-dependently inhibit vasoconstriction of forearm resistance vessels in humans. Hypertension 1993; 21:22.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harris WS, Rambjør GS, Windsor SL, Diederich D. n-3 fatty acids and urinary excretion of nitric oxide metabolites in humans. Am J Clin Nutr 1997; 65:459.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mori TA, Watts GF, Burke V, et al. Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Circulation 2000; 102:1264.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McVeigh GE, Brennan GM, Cohn JN, et al. Fish oil improves arterial compliance in non-insulin-dependent diabetes mellitus. Arterioscler Thromb 1994; 14:1425.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chu Z, Wei Y, Hao Y, et al. Clinical effectiveness of fish oil on arterial stiffness: A systematic review and meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis 2021; 31:1339.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mozaffarian D, Geelen A, Brouwer IA, et al. Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation 2005; 112:1945.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hidayat K, Yang J, Zhang Z, et al. Effect of omega-3 long-chain polyunsaturated fatty acid supplementation on heart rate: a meta-analysis of randomized controlled trials. Eur J Clin Nutr 2018; 72:805.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mozaffarian D, Prineas RJ, Stein PK, Siscovick DS. Dietary fish and n-3 fatty acid intake and cardiac electrocardiographic parameters in humans. J Am Coll Cardiol 2006; 48:478.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Billman GE, Kang JX, Leaf A. Prevention of ischemia-induced cardiac sudden death by n-3 polyunsaturated fatty acids in dogs. Lipids 1997; 32:1161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Keefe JH Jr, Abuissa H, Sastre A, et al. Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. Am J Cardiol 2006; 97:1127.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rantanen JM, Riahi S, Johansen MB, et al. Effects of Marine n-3 Polyunsaturated Fatty Acids on Heart Rate Variability and Heart Rate in Patients on Chronic Dialysis: A Randomized Controlled Trial. Nutrients 2018; 10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kristensen S, Schmidt EB, Schlemmer A, et al. The effect of marine n-3 polyunsaturated fatty acids on cardiac autonomic and hemodynamic function in patients with psoriatic arthritis: a randomised, double-blind, placebo-controlled trial. Lipids Health Dis 2016; 15:216.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sauder KA, Skulas-Ray AC, Campbell TS, et al. Effects of omega-3 fatty acid supplementation on heart rate variability at rest and during acute stress in adults with moderate hypertriglyceridemia. Psychosom Med 2013; 75:382.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xin W, Wei W, Li XY. Short-term effects of fish-oil supplementation on heart rate variability in humans: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2013; 97:926.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang YW, Morita I, Yao XS, Murota S. Pretreatment with eicosapentaenoic acid prevented hypoxia/reoxygenation-induced abnormality in endothelial gap junctional intercellular communication through inhibiting the tyrosine kinase activity. Prostaglandins Leukot Essent Fatty Acids 1999; 61:33.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sarrazin JF, Comeau G, Daleau P, et al. Reduced incidence of vagally induced atrial fibrillation and expression levels of connexins by n-3 polyunsaturated fatty acids in dogs. J Am Coll Cardiol 2007; 50:1505.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mozaffarian D. Fish oil and prevention of atrial fibrillation. J Am Coll Cardiol 2007; 50:1513.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grimsgaard S, Bønaa KH, Hansen JB, Myhre ES. Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans. Am J Clin Nutr 1998; 68:52.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oikonomou E, Vogiatzi G, Karlis D, et al. Effects of omega-3 polyunsaturated fatty acids on fibrosis, endothelial function and myocardial performance, in ischemic heart failure patients. Clin Nutr 2019; 38:1188.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McLennan PL, Barnden LR, Bridle TM, et al. Dietary fat modulation of left ventricular ejection fraction in the marmoset due to enhanced filling. Cardiovasc Res 1992; 26:871.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Charnock JS, McLennan PL, Abeywardena MY. Dietary modulation of lipid metabolism and mechanical performance of the heart. Mol Cell Biochem 1992; 116:19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ghio S, Scelsi L, Latini R, et al. Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial. Eur J Heart Fail 2010; 12:1345.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nodari S, Triggiani M, Campia U, et al. Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy. J Am Coll Cardiol 2011; 57:870.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peoples GE, McLennan PL, Howe PR, Groeller H. Fish oil reduces heart rate and oxygen consumption during exercise. J Cardiovasc Pharmacol 2008; 52:540.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Robinson JG, Stone NJ. Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids. Am J Cardiol 2006; 98:39i.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kris-Etherton PM, Harris WS, Appel LJ, American Heart Association. Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002; 106:2747.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang Q, Liang X, Wang L, et al. Effect of omega-3 fatty acids supplementation on endothelial function: a meta-analysis of randomized controlled trials. Atherosclerosis 2012; 221:536.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Knapp HR, Reilly IA, Alessandrini P, FitzGerald GA. In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. N Engl J Med 1986; 314:937.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 2000; 71:343S.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spite M, Serhan CN. Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins. Circ Res 2010; 107:1170.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Mahoney LL, Matu J, Price OJ, et al. Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials. Cardiovasc Diabetol 2018; 17:98.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xu T, Sun Y, Sun W, et al. Effect of omega-3 fatty acid supplementation on serum lipids and vascular inflammation in patients with end-stage renal disease: a meta-analysis. Sci Rep 2016; 6:39346.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li K, Huang T, Zheng J, et al. Effect of marine-derived n-3 polyunsaturated fatty acids on C-reactive protein, interleukin 6 and tumor necrosis factor α: a meta-analysis. PLoS One 2014; 9:e88103.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhou J, Tang G, Tang S, Yuan W. The effect of fish oil on inflammation markers in adult patients undergoing hemodialysis: A meta-analysis. Semin Dial 2022; 35:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morvaridzadeh M, Sepidarkish M, Yavari M, et al. The effects of omega-3 fatty acid supplementation on inflammatory factors in HIV-infected patients: A systematic review and meta-analysis of randomized clinical trials. Cytokine 2020; 136:155298.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tosatti JAG, Alves MT, Cândido AL, et al. Influence of n-3 fatty acid supplementation on inflammatory and oxidative stress markers in patients with polycystic ovary syndrome: a systematic review and meta-analysis. Br J Nutr 2021; 125:657.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           So J, Wu D, Lichtenstein AH, et al. EPA and DHA differentially modulate monocyte inflammatory response in subjects with chronic inflammation in part via plasma specialized pro-resolving lipid mediators: A randomized, double-blind, crossover study. Atherosclerosis 2021; 316:90.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vors C, Allaire J, Mejia SB, et al. Comparing the Effects of Docosahexaenoic and Eicosapentaenoic Acids on Inflammation Markers Using Pairwise and Network Meta-Analyses of Randomized Controlled Trials. Adv Nutr 2021; 12:128.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu JH, Micha R, Imamura F, et al. Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis. Br J Nutr 2012; 107 Suppl 2:S214.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akinkuolie AO, Ngwa JS, Meigs JB, Djoussé L. Omega-3 polyunsaturated fatty acid and insulin sensitivity: a meta-analysis of randomized controlled trials. Clin Nutr 2011; 30:702.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gao C, Liu Y, Gan Y, et al. Effects of fish oil supplementation on glucose control and lipid levels among patients with type 2 diabetes mellitus: a Meta-analysis of randomized controlled trials. Lipids Health Dis 2020; 19:87.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hou M, Zhou W, Sun L, et al. Effect of Fish Oil on Insulin Sensitivity in Children: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials. Can J Diabetes 2021; 45:531.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu JH, Cahill LE, Mozaffarian D. Effect of fish oil on circulating adiponectin: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 2013; 98:2451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bahreini M, Ramezani AH, Shishehbor F, Mansoori A. The Effect of Omega-3 on Circulating Adiponectin in Adults With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Can J Diabetes 2018; 42:553.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang YY, Liu W, Zhao TY, Tian HM. Efficacy of Omega-3 Polyunsaturated Fatty Acids Supplementation in Managing Overweight and Obesity: A Meta-Analysis of Randomized Clinical Trials. J Nutr Health Aging 2017; 21:187.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee CH, Fu Y, Yang SJ, Chi CC. Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on Non-Alcoholic Fatty Liver: A Systematic Review and Meta-Analysis. Nutrients 2020; 12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Masson S, Latini R, Tacconi M, Bernasconi R. Incorporation and washout of n-3 polyunsaturated fatty acids after diet supplementation in clinical studies. J Cardiovasc Med (Hagerstown) 2007; 8 Suppl 1:S4.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nordøy A, Barstad L, Connor WE, Hatcher L. Absorption of the n-3 eicosapentaenoic and docosahexaenoic acids as ethyl esters and triglycerides by humans. Am J Clin Nutr 1991; 53:1185.
          </a>
         </li>
         <li class="breakAll">
          US Department of Agriculture. USDA National Nutrient Database for Standard Reference: Release 18 (2005). US Department of Agriculture, Agricultural Research Service, 2006.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Burdge GC, Calder PC. Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev 2005; 45:581.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martinez M. Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 1992; 120:S129.
          </a>
         </li>
         <li class="breakAll">
          Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Micronutrients). The National Academies Press; Washington, DC 2002/2005.
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCann JC, Ames BN. Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am J Clin Nutr 2005; 82:281.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lewin GA, Schachter HM, Yuen D, et al. Effects of omega-3 fatty acids on child and maternal health. Evid Rep Technol Assess (Summ) 2005; :1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           León H, Shibata MC, Sivakumaran S, et al. Effect of fish oil on arrhythmias and mortality: systematic review. BMJ 2008; 337:a2931.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marik PE, Varon J. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin Cardiol 2009; 32:365.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           He K, Song Y, Daviglus ML, et al. Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 2004; 109:2705.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saravanan P, Davidson NC, Schmidt EB, Calder PC. Cardiovascular effects of marine omega-3 fatty acids. Lancet 2010; 376:540.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mente A, de Koning L, Shannon HS, Anand SS. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 2009; 169:659.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Assadourian JN, Peterson ED, McDonald SA, et al. Health Claims and Doses of Fish Oil Supplements in the US. JAMA Cardiol 2023; 8:984.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ito MK. A Comparative Overview of Prescription Omega-3 Fatty Acid Products. P T 2015; 40:826.
          </a>
         </li>
         <li class="breakAll">
          Drugs@FDA: FDA-approved drugs. US Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm (Accessed on October 24, 2023).
         </li>
         <li class="breakAll">
          Santerre C, November 9, 2007, personal communication.
         </li>
         <li class="breakAll">
          Omacor: Consumer drug information sheet - Approval label. US Food and Drug Administration, Center for Drug Evaluation and Research. www.fda.gov/cder/foi/label/2004/21654lbl.pdf (Accessed on December 21, 2007).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chee KM, Gong JX, Rees DM, et al. Fatty acid content of marine oil capsules. Lipids 1990; 25:523.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Villani AM, Crotty M, Cleland LG, et al. Fish oil administration in older adults: is there potential for adverse events? A systematic review of the literature. BMC Geriatr 2013; 13:41.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lien EL. Toxicology and safety of DHA. Prostaglandins Leukot Essent Fatty Acids 2009; 81:125.
          </a>
         </li>
         <li class="breakAll">
          Letter responding to a request to reconsider the qualified claim for a dietary supplement health claim for omega-3 fatty acids and coronary heart disease. Office of Nutritional Products, Labeling, and Dietary Supplements, Center for Food Safety and Applied Nutrition, US Food and Drug Administration, 2002. www.cfsan.fda.gov/~dms/ds-ltr28.html (Accessed on December 21, 2007).
         </li>
         <li class="breakAll">
          Substances affirmed as Generally Recognized As Safe: Menhaden oil. Department of Health and Human Services, US Food and Drug Administration. www.fda.gov/OHRMS/DOCKETS/98fr/05-5641.htm (Accessed on June 30, 2008).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manson JE, Cook NR, Lee IM, et al. Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer. N Engl J Med 2019; 380:23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abdelhamid AS, Brown TJ, Brainard JS, et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev 2020; 3:CD003177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akintoye E, Sethi P, Harris WS, et al. Fish Oil and Perioperative Bleeding. Circ Cardiovasc Qual Outcomes 2018; 11:e004584.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Foran SE, Flood JG, Lewandrowski KB. Measurement of mercury levels in concentrated over-the-counter fish oil preparations: is fish oil healthier than fish? Arch Pathol Lab Med 2003; 127:1603.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jacobs MN, Covaci A, Schepens P. Investigation of selected persistent organic pollutants in farmed Atlantic salmon (Salmo salar), salmon aquaculture feed, and fish oil components of the feed. Environ Sci Technol 2002; 36:2797.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Storelli MM, Storelli A, Marcotrigiano GO. Polychlorinated biphenyls, hexachlorobenzene, hexachlorocyclohexane isomers, and pesticide organochlorine residues in cod-liver oil dietary supplements. J Food Prot 2004; 67:1787.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jimenez B, Wright C, Kelly M, Startin JR. Levels of PCDDs, PCDFs and non-ortho PCBs in dietary supplement fish oil obtained in Spain. Chemosphere 1996; 32:461.
          </a>
         </li>
         <li class="breakAll">
          Summary of investigation of dioxins, furans, and PCBs in farmed salmon, wild salmon, farmed trout and fish oil capsules. Food Safety Authority of Ireland., March 2002.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wiseman M. The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc 2008; 67:253.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sala-Vila A, Calder PC. Update on the relationship of fish intake with prostate, breast, and colorectal cancers. Crit Rev Food Sci Nutr 2011; 51:855.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brasky TM, Till C, White E, et al. Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial. Am J Epidemiol 2011; 173:1429.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Park SY, Wilkens LR, Henning SM, et al. Circulating fatty acids and prostate cancer risk in a nested case-control study: the Multiethnic Cohort. Cancer Causes Control 2009; 20:211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brasky TM, Darke AK, Song X, et al. Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. J Natl Cancer Inst 2013; 105:1132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chavarro JE, Stampfer MJ, Li H, et al. A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2007; 16:1364.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alexander DD, Bassett JK, Weed DL, et al. Meta-Analysis of Long-Chain Omega-3 Polyunsaturated Fatty Acids (LCω-3PUFA) and Prostate Cancer. Nutr Cancer 2015; 67:543.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fu YQ, Zheng JS, Yang B, Li D. Effect of individual omega-3 fatty acids on the risk of prostate cancer: a systematic review and dose-response meta-analysis of prospective cohort studies. J Epidemiol 2015; 25:261.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5365 Version 77.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Bang HO, Dyerberg J. Lipid metabolism and ischemic heart disease in Greenland Eskimos. In: Advances in nutrition research, Draper H (Ed), Plenum Press, New York 1980. p.1–22.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3990713" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : The inverse relation between fish consumption and 20-year mortality from coronary heart disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2571009" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2053338" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7563561" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7635594" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : The protective effect of a small amount of fish on coronary heart disease mortality in an elderly population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9091800" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Fish consumption and the 30-year risk of fatal myocardial infarction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9424039" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Fish consumption and risk of sudden cardiac death.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10465168" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10853639" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Fish consumption and coronary heart disease mortality in Finland, Italy, and The Netherlands.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11682363" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Fish and shellfish consumption in relation to death from myocardial infarction among men in Shanghai, China.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11939867" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Fish and omega-3 fatty acid intake and risk of coronary heart disease in women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11948270" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Blood levels of long-chain n-3 fatty acids and the risk of sudden death.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12540389" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12642356" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15630029" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10617972" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Prevention of fatal cardiac arrhythmias by polyunsaturated fatty acids.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11837983" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Myocardial membrane fatty acids and the antiarrhythmic actions of dietary fish oil in animal models.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12782616" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16825676" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17047219" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Fish intake, contaminants, and human health: evaluating the risks and the benefits.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17398308" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17398308" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22051327" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22051327" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22051327" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9129504" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : n-3 fatty acids and serum lipoproteins: human studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16530201" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15133888" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Effects of omega-3 fatty acids on cardiovascular disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29583081" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Lipid Effects of Icosapent Ethyl in Women with Diabetes Mellitus and Persistent High Triglycerides on Statin Treatment: ANCHOR Trial Subanalysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16832161" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Why do omega-3 fatty acids lower serum triglycerides?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28797250" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23525440" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25277614" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Fish oil for the reduction of atrial fibrillation recurrence, inflammation, and oxidative stress.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21078810" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23265344" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation: Results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25465932" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Effect of omega-three polyunsaturated fatty acids on inflammation, oxidative stress, and recurrence of atrial fibrillation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23541970" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Fish oil and post-operative atrial fibrillation: a meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34612056" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Effect of Long-Term Marineɷ-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30415628" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33191772" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction: A Randomized, Controlled Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33190147" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24610882" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33987149" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Effects of Fish Oil Supplementation on Cardiometabolic Risk Factors in Overweight or Obese Children and Adolescents: A Meta-Analysis of Randomized Controlled Trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16442366" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Intake of tuna or other broiled or baked fish versus fried fish and cardiac structure, function, and hemodynamics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10863956" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Effect of dietary polyunsaturated fatty acids on contractile function of hearts isolated from sedentary and trained rats.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11163359" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Eicosapentaenoic acid (EPA) induces Ca(2+)-independent activation and translocation of endothelial nitric oxide synthase and endothelium-dependent vasorelaxation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10617974" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Fatty acid modulation of endothelial activation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17125900" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Eicosapentaenoic acid modifies lipid composition in caveolae and induces translocation of endothelial nitric oxide synthase.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17662956" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Docosahexaenoic acid affects endothelial nitric oxide synthase in caveolae.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1442589" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Effect of omega-3 fatty acids on the vascular response to angiotensin in normotensive men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8418020" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Marine oils dose-dependently inhibit vasoconstriction of forearm resistance vessels in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9022531" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : n-3 fatty acids and urinary excretion of nitric oxide metabolites in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10982541" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8068603" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Fish oil improves arterial compliance in non-insulin-dependent diabetes mellitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33741211" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Clinical effectiveness of fish oil on arterial stiffness: A systematic review and meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16172267" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29284786" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Effect of omega-3 long-chain polyunsaturated fatty acid supplementation on heart rate: a meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16875972" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Dietary fish and n-3 fatty acid intake and cardiac electrocardiographic parameters in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9397401" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Prevention of ischemia-induced cardiac sudden death by n-3 polyunsaturated fatty acids in dogs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16616012" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30227610" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Effects of Marine n-3 Polyunsaturated Fatty Acids on Heart Rate Variability and Heart Rate in Patients on Chronic Dialysis: A Randomized Controlled Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27955663" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : The effect of marine n-3 polyunsaturated fatty acids on cardiac autonomic and hemodynamic function in patients with psoriatic arthritis: a randomised, double-blind, placebo-controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23592752" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Effects of omega-3 fatty acid supplementation on heart rate variability at rest and during acute stress in adults with moderate hypertriglyceridemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23515005" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Short-term effects of fish-oil supplementation on heart rate variability in humans: a meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10477040" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Pretreatment with eicosapentaenoic acid prevented hypoxia/reoxygenation-induced abnormality in endothelial gap junctional intercellular communication through inhibiting the tyrosine kinase activity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17919572" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Reduced incidence of vagally induced atrial fibrillation and expression levels of connexins by n-3 polyunsaturated fatty acids in dogs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17919573" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Fish oil and prevention of atrial fibrillation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9665096" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29752009" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Effects of omega-3 polyunsaturated fatty acids on fibrosis, endothelial function and myocardial performance, in ischemic heart failure patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1451164" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Dietary fat modulation of left ventricular ejection fraction in the marmoset due to enhanced filling.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1480148" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Dietary modulation of lipid metabolism and mechanical performance of the heart.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20952767" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21215550" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19034030" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Fish oil reduces heart rate and oxygen consumption during exercise.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16919516" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12438303" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22317966" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Effect of omega-3 fatty acids supplementation on endothelial function: a meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3007982" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10617994" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Dietary polyunsaturated fatty acids and inflammatory mediator production.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21071715" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29981570" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28008943" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Effect of omega-3 fatty acid supplementation on serum lipids and vascular inflammation in patients with end-stage renal disease: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24505395" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Effect of marine-derived n-3 polyunsaturated fatty acids on C-reactive protein, interleukin 6 and tumor necrosis factorα: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34459522" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : The effect of fish oil on inflammation markers in adult patients undergoing hemodialysis: A meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32977239" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : The effects of omega-3 fatty acid supplementation on inflammatory factors in HIV-infected patients: A systematic review and meta-analysis of randomized clinical trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32799935" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Influence of n-3 fatty acid supplementation on inflammatory and oxidative stress markers in patients with polycystic ovary syndrome: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33303222" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : EPA and DHA differentially modulate monocyte inflammatory response in subjects with chronic inflammation in part via plasma specialized pro-resolving lipid mediators: A randomized, double-blind, crossover study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32790827" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Comparing the Effects of Docosahexaenoic and Eicosapentaenoic Acids on Inflammation Markers Using Pairwise and Network Meta-Analyses of Randomized Controlled Trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22591895" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21959352" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Omega-3 polyunsaturated fatty acid and insulin sensitivity: a meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32384902" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Effects of fish oil supplementation on glucose control and lipid levels among patients with type 2 diabetes mellitus: a Meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33388274" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Effect of Fish Oil on Insulin Sensitivity in Children: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23703724" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Effect of fish oil on circulating adiponectin: a systematic review and meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29567080" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : The Effect of Omega-3 on Circulating Adiponectin in Adults With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28112774" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Efficacy of Omega-3 Polyunsaturated Fatty Acids Supplementation in Managing Overweight and Obesity: A Meta-Analysis of Randomized Clinical Trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32932796" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on Non-Alcoholic Fatty Liver: A Systematic Review and Meta-Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17876198" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Incorporation and washout of n-3 polyunsaturated fatty acids after diet supplementation in clinical studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1826985" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Absorption of the n-3 eicosapentaenoic and docosahexaenoic acids as ethyl esters and triglycerides by humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1826985" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Absorption of the n-3 eicosapentaenoic and docosahexaenoic acids as ethyl esters and triglycerides by humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16188209" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1532827" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Tissue levels of polyunsaturated fatty acids during early human development.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1532827" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Tissue levels of polyunsaturated fatty acids during early human development.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16087970" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16194124" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Effects of omega-3 fatty acids on child and maternal health.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19106137" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Effect of fish oil on arrhythmias and mortality: systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19609891" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15184295" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20638121" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Cardiovascular effects of marine omega-3 fatty acids.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19364995" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37610733" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Health Claims and Doses of Fish Oil Supplements in the US.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26681905" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : A Comparative Overview of Prescription Omega-3 Fatty Acid Products.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26681905" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : A Comparative Overview of Prescription Omega-3 Fatty Acid Products.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26681905" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : A Comparative Overview of Prescription Omega-3 Fatty Acid Products.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26681905" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : A Comparative Overview of Prescription Omega-3 Fatty Acid Products.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2250588" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Fatty acid content of marine oil capsules.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23634646" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Fish oil administration in older adults: is there potential for adverse events? A systematic review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19501496" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Toxicology and safety of DHA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19501496" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Toxicology and safety of DHA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19501496" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Toxicology and safety of DHA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30415637" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32114706" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30571332" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Fish Oil and Perioperative Bleeding.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14632570" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Measurement of mercury levels in concentrated over-the-counter fish oil preparations: is fish oil healthier than fish?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12144249" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Investigation of selected persistent organic pollutants in farmed Atlantic salmon (Salmo salar), salmon aquaculture feed, and fish oil components of the feed.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15330552" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Polychlorinated biphenyls, hexachlorobenzene, hexachlorocyclohexane isomers, and pesticide organochlorine residues in cod-liver oil dietary supplements.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8907223" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Levels of PCDDs, PCDFs and non-ortho PCBs in dietary supplement fish oil obtained in Spain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8907223" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : Levels of PCDDs, PCDFs and non-ortho PCBs in dietary supplement fish oil obtained in Spain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18452640" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21888535" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : Update on the relationship of fish intake with prostate, breast, and colorectal cancers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21518693" id="rid130" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          131 : Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18821021" id="rid131" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          132 : Circulating fatty acids and prostate cancer risk in a nested case-control study: the Multiethnic Cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23843441" id="rid132" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          133 : Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17585059" id="rid133" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          134 : A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25826711" id="rid134" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          135 : Meta-Analysis of Long-Chain Omega-3 Polyunsaturated Fatty Acids (LCω-3PUFA) and Prostate Cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25787237" id="rid135" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          136 : Effect of individual omega-3 fatty acids on the risk of prostate cancer: a systematic review and dose-response meta-analysis of prospective cohort studies.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
